The adjuvant effect of TLR agonists on CD4+ effector T cells is under the indirect control of regulatory T cells

Department of Immunology, Paris, France.
European Journal of Immunology (Impact Factor: 4.03). 08/2011; 41(8):2303-13. DOI: 10.1002/eji.201041387
Source: PubMed


TLR agonists have been suggested to directly impact Tregs, thereby enhancing or reversing their suppressive function. Here, in order to select TLR agonists leading to potent effector T-cell responses, while minimizing Treg inhibitory function, we used a model antigen, covalently linked to an inert delivery system, combined with a large panel of TLR agonists, for the immunization of mice with an attenuated/depleted or intact Treg subset. We observed that the negative modulation of effector CD4(+) T cells exerted by Tregs cannot be circumvented, whatever the TLR agonist used as adjuvant. To better understand the impact of TLR agonists on Tregs, we investigated (i) the TLR expression profile of highly purified CD4(+) Foxp3(+) Tregs, at steady state or subsequent to in vivo activation by TLR agonists and (ii) the Treg phenotype after in vivo and in vitro activation by TLR agonists. Our results demonstrate that TLR agonists, as single signal inducers, are not able to directly activate Tregs. The phenotypic Treg activation observed in vivo, following TLR administration, does not result from cross-talk with conventional T cells but is rather a consequence of the interaction with other immune cell type(s).

Download full-text


Available from: Tim D Sparwasser, Jan 31, 2014
  • Source
    • "Murine Tregs express almost all of the identified TLR genes [37,38], and TLR (e.g., TLR2, 4, 7, 8, 9) signaling has a direct impact on Treg function [38,39]. However, the exact roles for specific TLR ligands or agonists in enhancing or reversing Treg function are somewhat controversial [32,37–42], which may be due to the different immune contexts studied. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Immunization with high-dose heat shock protein gp96, an endoplasmic reticulum counterpart of the Hsp90 family, significantly enhances regulatory T cell (Treg) frequency and suppressive function. Here, we examined the potential role and mechanism of gp96 in regulating immune-mediated hepatic injury in mice. High-dose gp96 immunization elicited rapid and long-lasting protection of mice against concanavalin A (Con A)-and anti-CD137-induced liver injury, as evidenced by decreased alanine aminotransaminase (ALT) levels, hepatic necrosis, serum pro-inflammatory cytokines (IFN-γ, TNF-α, and IL-6), and number of IFN-γ (+) CD4(+) and IFN-γ (+) CD8(+) T cells in the spleen and liver. In contrast, CD4(+)CD25(+)Foxp3(+) Treg frequency and suppressive function were both increased, and the protective effect of gp96 could be generated by adoptive transfer of Treg cells from gp96-immunized mice. In vitro co-culture experiments demonstrated that gp96 stimulation enhanced Treg proliferation and suppressive function, and up-regulation of Foxp3, IL-10, and TGF-β1 induced by gp96 was dependent on TLR2- and TLR4-mediated NF-κB activation. Our work shows that activation of Tregs by high-dose gp96 immunization protects against Con A- and anti-CD137-induced T cell-hepatitis and provides therapeutic potential for the development of a gp96-based anti-immune hyperactivation vaccine against immune-mediated liver destruction.
    PLoS ONE 07/2013; 8(7):e68997. DOI:10.1371/journal.pone.0068997 · 3.23 Impact Factor
  • Source
    • "Here, TLR activation per se did not lead to an expansion of Tregs, but concomitant TLR activation and Treg depletion led to enhanced IFN-g production. With the exception of low levels of TLR2, no other TLRs were expressed on highly purified CD4 + Foxp3 + Tregs (Chen et al., 2009; Olivier et al., 2011). However, ligation of TLR9 or TLR7 led to an indirect activation of Tregs as indicated by CD69 upregulation . "
    [Show abstract] [Hide abstract]
    ABSTRACT: The development of effective vaccines against life-threatening pathogens in human diseases represents one of the biggest challenges in biomedical science. Vaccines traditionally make use of the body's own immune armoury to combat pathogens. Yet, while our immune system is mostly effective in eliminating or controlling a diverse range of microorganisms, its responses are incomplete or somewhat limited in several other cases. How immune responses are restrained during certain infections has been a matter of debate for many years. The discovery of regulatory T cells (Tregs), an immune cell type that plays a central role in maintaining immune homeostasis and controlling appropriate immune responses, has shed light into many questions. Indeed, it has been proposed that while Tregs might be beneficial in preventing excessive tissue damage during infection, they might also favour pathogen persistence by restraining effector immune responses. In addition, Tregs are believed to limit immune responses upon vaccination. Different strategies have been pursued to circumvent Treg activity during immunization, but the lack of specific tools for their study has led sometimes to controversial conclusions. With the advent of novel mouse models that allow specific depletion and/or tracking of Treg populations in vivo, novel aspects of Treg biology during infection have been unravelled. In this review, we describe the new advances in understanding Treg biology during infection and evaluate Treg depletion as a novel adjuvant strategy for vaccination.
    Microbial Biotechnology 09/2011; 5(2):260-9. DOI:10.1111/j.1751-7915.2011.00299.x · 3.21 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is a permanent interaction amid the innate and adaptive immune systems that leads to a defensive immune response against pathogens and contributes substantially to self-nonself discrimination. Toll-like receptors (TLRs) are essential molecules of the innate immune system that stimulate numerous inflammatory pathways and harmonize systemic defense against a wide array of pathogens. In addition to identifying unique molecular patterns associated with various sections of pathogens, TLRs may also recognize a number of self proteins and endogenous nucleic acids. Several reports have indicated that inappropriate stimulation of the TLR pathway via endogenous or exogenous ligands in animal models or humans may lead to the induction and/or prolongation of autoimmune response and tissue injury.
    Human immunology 08/2011; 72(12):1188-93. DOI:10.1016/j.humimm.2011.08.015 · 2.14 Impact Factor
Show more